Cart
sales@molnova.com
KM 91104
CAS No. 304481-60-5
KM 91104( —— )
Catalog No. M24235 CAS No. 304481-60-5
KM 91104 is a cell permeable inhibitor of V-ATPase. KM91104 specifically targets the interaction between V-ATPase subunit A3 and subunit B2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 155 | In Stock |
|
| 10MG | 245 | In Stock |
|
| 25MG | 493 | In Stock |
|
| 50MG | 714 | In Stock |
|
| 100MG | 981 | In Stock |
|
| 500MG | 1998 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKM 91104
-
NoteResearch use only, not for human use.
-
Brief DescriptionKM 91104 is a cell permeable inhibitor of V-ATPase. KM91104 specifically targets the interaction between V-ATPase subunit A3 and subunit B2.
-
DescriptionKM 91104 is a cell permeable inhibitor of V-ATPase. KM91104 specifically targets the interaction between V-ATPase subunit A3 and subunit B2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorVacuolar type H+-ATPase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number304481-60-5
-
Formula Weight272.26
-
Molecular FormulaC14H12N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:50mg/ml(183.65mM; need ultrasonic); Etanol:3mg/ml(11.02mM; need ultrasonic)
-
SMILESOc1c(C=NNC(c(cc2)cc(O)c2O)=O)cccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.The adenosine monophosphate–activated protein kinase—vacuolar adenosine triphosphatase–pH axis: A key regulator of the profibrogenic phenotype of human hepatic stellate cells[J]. Hepatology, 2018, 68(3).
molnova catalog
related products
-
Rbin-1
Rbin-1 is a potentspecific inhibitor of eukaryotic ribosome biogenesis.?
-
Digoxin
Digoxin is occasionally used in the treatment of various heart conditions namely atrial fibrillation atrial flutter and sometimes heart failure that cannot be controlled by other medication.
-
Omecamtiv mecarbil
Omecamtiv mecarbil (CK-1827452) is the first potent cardiac myosin activator that can specifically activate the cardiac myosin S1 domain but not other muscle myosins.
